Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, Statland JM, Tawil R; ReSolve Investigators and the FSHD CTRN18.
LoRusso S, et al. Among authors: johnson ne.
BMC Neurol. 2019 Sep 10;19(1):224. doi: 10.1186/s12883-019-1452-x.
BMC Neurol. 2019.
PMID: 31506080
Free PMC article.